Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Hormonal and Radiotherapy in High-Risk Prostate Cancer
NCT00348998Phase 2Unknown
- Sponsor
- Virginia Mason
- Start
- Apr 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in prostate cancer (PCa), sponsored by Virginia Mason. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00348998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348998.